Evotec SE strengthens its leadership team with the appointment of Dr. Joanna Holbrook as CSO, tasking her with driving differentiation across its discovery, development, and innovation platforms.
Appointment of Dr. Joanna Holbrook as CSO and Management Board member is a leadership change that may strengthen scientific strategy but has no immediate financial impact.
Evotec SE has named Dr. Joanna Holbrook as its new Chief Scientific Officer and member of the Management Board. Dr. Holbrook brings over 25 years of experience across the pharmaceutical, biotechnology, and academic sectors to lead the company's global scientific strategy.
Dr. Holbrook serves as the Chief Scientific Officer and a member of the Management Board, responsible for leading global scientific strategy and driving differentiation across the company's service and innovation platforms.